Form 4 for VTVT vTv Therapeutics Inc.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001415889-24-005996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-02-29 | 2024-02-27 | VTVT | AKKARAJU SRINIVAS | Dir, 10% | A - Grant | $11.81 | +224.7K | 265.6K | +550% | +$2.65M |
| DI | 2024-02-29 | 2024-02-27 | VTVT | AKKARAJU SRINIVAS | Dir, 10% | A - Grant | $11.80 | +833.7K | 833.7K | New | +$9.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-27 | A | A | 224,732 | $11.81 | 265,620 | I By Samsara BioCapital, L.P. | — | — | (F1) These securities are held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. |
| 2 | Derivative | Pre- Funded Warrants (Right to Buy) | 2024-02-27 | A | A | 833,693 | $11.80 | 833,693 | I Samsara BioCapital, L.P. | $0.01 · — to — | 833,693 Class A Common Stock | (F1) These securities are held by Samsara BioCapital, L.P. ("Samsara LP"). Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. (F2) The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Class A Common Stock outstanding immediately after giving effect to such exercise. |